Literature DB >> 8252763

Phototoxic eruptions due to doxycycline--a dose-related phenomenon.

A M Layton1, W J Cunliffe.   

Abstract

The tetracycline group of antibiotics still remains the most successful oral treatment for acne. They are relatively free from side-effects apart from the occasional gastrointestinal upset or vaginal candidosis. Rarer side-effects include drug rashes, pigmentation with minocycline and a light-sensitive eruption with doxycycline. The incidence of light-sensitive rashes with doxycycline at a dose of 100 mg daily, is in the order of 3%. Acne does not always respond to conventional regimens of antibiotics and higher dosages may be required. We report a highly significant incidence of light-sensitive eruptions in patients receiving doxycycline at a daily dose of 150 mg or above.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252763     DOI: 10.1111/j.1365-2230.1993.tb02242.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  10 in total

Review 1.  Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2015-05

Review 2.  Drug-induced photosensitivity: culprit drugs, management and prevention.

Authors:  Aaron M Drucker; Cheryl F Rosen
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

Review 3.  Guidelines for the management of acne vulgaris in adolescents.

Authors:  Victoria Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  Safety and efficacy of doxycycline in the treatment of rosacea.

Authors:  Sheila Valentín; Adisbeth Morales; Jorge L Sánchez; Abimael Rivera
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-08-12

5.  Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis.

Authors:  Kathrine R Tan; Alan J Magill; Monica E Parise; Paul M Arguin
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

Review 6.  Drug triggered pruritus, rash, papules, and blisters - is AGEP a clash of an altered sphingolipid-metabolism and lysosomotropism of drugs accumulating in the skin?

Authors:  Markus Blaess; Lars Kaiser; Oliver Sommerfeld; René Csuk; Hans-Peter Deigner
Journal:  Lipids Health Dis       Date:  2021-11-08       Impact factor: 3.876

7.  Tetracycline use and risk of incident skin cancer: a prospective study.

Authors:  Wen-Qing Li; Aaron M Drucker; Eunyoung Cho; Francine Laden; Trang VoPham; Suyun Li; Martin A Weinstock; Abrar A Qureshi
Journal:  Br J Cancer       Date:  2017-10-26       Impact factor: 7.640

8.  Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction.

Authors:  Kerry B Hagen; Raman Bedi; Caroline A Blackie; Kellie J Christenson-Akagi
Journal:  Clin Ophthalmol       Date:  2018-01-17

Review 9.  Safety of antimalarial medications for use while scuba diving in malaria Endemic Regions.

Authors:  Kyle Petersen; David P Regis
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-10-11

10.  Doxycycline-induced photosensitivity in patients treated for erythema migrans.

Authors:  Maša Velušček; Fajko F Bajrović; Franc Strle; Daša Stupica
Journal:  BMC Infect Dis       Date:  2018-08-03       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.